Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Xiaozhuo Liu, Kristopher Attwood, Stuthi Perimbeti, Rohit Jain et al.
Citations
1 citations
Journal
Cancer Chemotherapy and Pharmacology
Topics
Prostate Cancer Treatment and Research
Field-Weighted Citation Impact (FWCI)
1.52
article
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Xiaozhuo Liu, Kristopher Attwood, Stuthi Perimbeti, Rohit Jain, Jan H. Beumer, David I. Quinn, Changchuan Jiang, Kelly Green, Jason Kirk, Dharmesh Gopalakrishnan, Anmbreen Jamroze, Robert R. Bies, Robert A. Parise, Dean G. Tang, Julianne L. Holleran, Gurkamal Chatta
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer Chemotherapy and PharmacologyVol. 95(1)
Institutions
Abu Dhabi University (AE), Roswell Park Comprehensive Cancer Center (US), Johns Hopkins University (US), University of Pittsburgh (US), Cornell University (US), AbbVie (United States) (US), Presbyterian Hospital (US), Abu Dhabi Health Services (AE), UPMC Hillman Cancer Center (US), Sidney Kimmel Comprehensive Cancer Center (US), University at Buffalo, State University of New York (US), Penn State Milton S. Hershey Medical Center (US), The University of Texas Southwestern Medical Center (US)
Funders
U.S. Department of Defense, Prostate Cancer Foundation, Roswell Park Cancer Institute, National Institutes of Health, National Cancer Institute